JP2019501896A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501896A5 JP2019501896A5 JP2018529622A JP2018529622A JP2019501896A5 JP 2019501896 A5 JP2019501896 A5 JP 2019501896A5 JP 2018529622 A JP2018529622 A JP 2018529622A JP 2018529622 A JP2018529622 A JP 2018529622A JP 2019501896 A5 JP2019501896 A5 JP 2019501896A5
- Authority
- JP
- Japan
- Prior art keywords
- branched
- linear
- heterocyclyl
- haloalkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 35
- 239000001257 hydrogen Substances 0.000 claims 35
- 125000001072 heteroaryl group Chemical group 0.000 claims 27
- 125000003118 aryl group Chemical group 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- 150000002431 hydrogen Chemical class 0.000 claims 21
- 150000003839 salts Chemical class 0.000 claims 15
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 150000002367 halogens Chemical class 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 241000894006 Bacteria Species 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 241000588921 Enterobacteriaceae Species 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 241000589291 Acinetobacter Species 0.000 claims 1
- 241001453380 Burkholderia Species 0.000 claims 1
- 241000588923 Citrobacter Species 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- 241000588914 Enterobacter Species 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000588748 Klebsiella Species 0.000 claims 1
- 241000588621 Moraxella Species 0.000 claims 1
- 241000588771 Morganella <proteobacterium> Species 0.000 claims 1
- 208000003926 Myelitis Diseases 0.000 claims 1
- 208000001388 Opportunistic Infections Diseases 0.000 claims 1
- 206010048685 Oral infection Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 208000002389 Pouchitis Diseases 0.000 claims 1
- 241000588769 Proteus <enterobacteria> Species 0.000 claims 1
- 241000588768 Providencia Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 241000607720 Serratia Species 0.000 claims 1
- 241000607768 Shigella Species 0.000 claims 1
- 241000122971 Stenotrophomonas Species 0.000 claims 1
- 208000033809 Suppuration Diseases 0.000 claims 1
- 206010048038 Wound infection Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 201000005008 bacterial sepsis Diseases 0.000 claims 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical group C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010014665 endocarditis Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 208000019206 urinary tract infection Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562264628P | 2015-12-08 | 2015-12-08 | |
| US62/264,628 | 2015-12-08 | ||
| PCT/IB2016/057451 WO2017098440A1 (en) | 2015-12-08 | 2016-12-08 | Substituted benzazinones as antibacterial compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019501896A JP2019501896A (ja) | 2019-01-24 |
| JP2019501896A5 true JP2019501896A5 (OSRAM) | 2020-01-23 |
Family
ID=57680436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018529622A Pending JP2019501896A (ja) | 2015-12-08 | 2016-12-08 | 抗菌化合物としての置換ベンザジノン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10781184B2 (OSRAM) |
| EP (1) | EP3386950A1 (OSRAM) |
| JP (1) | JP2019501896A (OSRAM) |
| KR (1) | KR20180088456A (OSRAM) |
| CN (1) | CN108368053A (OSRAM) |
| AU (2) | AU2016367510A1 (OSRAM) |
| BR (1) | BR112018011670A2 (OSRAM) |
| CA (1) | CA3007653A1 (OSRAM) |
| RU (1) | RU2018124788A (OSRAM) |
| WO (1) | WO2017098440A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| AR105646A1 (es) | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
| AR105889A1 (es) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
| PT3519387T (pt) * | 2016-09-28 | 2021-09-28 | Dong A St Co Ltd | Derivados de tetrahidropiridina e sua utilização como agentes antibacterianos |
| CN109593066B (zh) * | 2018-12-21 | 2020-06-19 | 上海交通大学 | 一种用于治疗肠道细菌感染的叶酸拮抗剂及其制备与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101076018B1 (ko) * | 2003-01-08 | 2011-10-21 | 유니버시티 오브 워싱톤 | 항균제 |
| CA2691987C (en) * | 2007-06-12 | 2016-08-16 | Achaogen, Inc. | Antibacterial agents |
| CA2782453C (en) * | 2009-12-16 | 2015-11-24 | Matthew Frank Brown | N-linked hydroxamic acid derivatives useful as antibacterial agents |
| JP6514716B2 (ja) * | 2014-04-22 | 2019-05-15 | ノバルティス アーゲー | ＬｐｘＣ阻害剤としてのイソオキサゾリンヒドロキサム酸誘導体 |
| AU2015261540A1 (en) * | 2014-05-16 | 2017-01-12 | Idorsia Pharmaceuticals Ltd | Antibacterial quinazoline-4(3h)-one derivatives |
-
2016
- 2016-12-08 JP JP2018529622A patent/JP2019501896A/ja active Pending
- 2016-12-08 AU AU2016367510A patent/AU2016367510A1/en not_active Abandoned
- 2016-12-08 CN CN201680072228.9A patent/CN108368053A/zh active Pending
- 2016-12-08 US US16/060,641 patent/US10781184B2/en not_active Expired - Fee Related
- 2016-12-08 KR KR1020187019079A patent/KR20180088456A/ko not_active Withdrawn
- 2016-12-08 CA CA3007653A patent/CA3007653A1/en not_active Abandoned
- 2016-12-08 WO PCT/IB2016/057451 patent/WO2017098440A1/en not_active Ceased
- 2016-12-08 RU RU2018124788A patent/RU2018124788A/ru not_active Application Discontinuation
- 2016-12-08 BR BR112018011670A patent/BR112018011670A2/pt not_active Application Discontinuation
- 2016-12-08 EP EP16819668.1A patent/EP3386950A1/en not_active Withdrawn
-
2019
- 2019-11-27 AU AU2019271952A patent/AU2019271952A1/en not_active Abandoned
-
2020
- 2020-09-08 US US17/014,386 patent/US20210053926A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501896A5 (OSRAM) | ||
| HRP20190603T1 (hr) | 2-supstituirani spojevi cefema | |
| JP2016520618A5 (OSRAM) | ||
| CN108570032B (zh) | 新型罗丹明染料及其在抗致病菌中的应用 | |
| TN2012000112A1 (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositons and their use | |
| NZ721534A (en) | Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | |
| JP2011513305A5 (OSRAM) | ||
| JP2011526283A5 (OSRAM) | ||
| JP2012506870A5 (OSRAM) | ||
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| JP7082445B2 (ja) | ウシ又はブタの呼吸器疾患を治療するための化合物 | |
| JP2015502974A5 (OSRAM) | ||
| JP2013523761A5 (OSRAM) | ||
| JP2016505007A5 (OSRAM) | ||
| RU2015132569A (ru) | Полимиксины, композиции с ними, способы получения и способы применения | |
| JP2015536947A5 (OSRAM) | ||
| JP2015531378A5 (OSRAM) | ||
| JP2017508817A5 (OSRAM) | ||
| JP2016503403A5 (OSRAM) | ||
| GEP20237522B (en) | Antibacterial compounds | |
| JP2018523675A5 (OSRAM) | ||
| JP2011526286A5 (OSRAM) | ||
| WO2012007913A3 (en) | Oral administration forms for controlled release of rifampicin or other antibiotics for the treatment of bacterial infections and inflammatory diseases of the gastrointestinal tract | |
| BR112018011670A2 (pt) | compostos antibacterianos | |
| WO2012073214A4 (en) | Heptose derivatives for use in the treatment of bacterial infections |